Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • 2026
  • Page 776
studying-mir172-family-in-phaseolus-vulgaris-under-metal-stress
Posted inBiotechnology

Studying miR172 Family in Phaseolus vulgaris Under Metal Stress

January 6, 2026
In a groundbreaking study recently published in BMC Genomics, researchers Öner, Aygören, Kasapoğlu, and colleagues have unveiled the intricate relationships…
Read More
boehringer-continues-kidney-disease-dealmaking-run-with-$120m-variant-bio-pact
Posted inBiotechnology

Boehringer continues kidney disease dealmaking run with $120M Variant Bio pact

January 6, 2026
Boehringer Ingelheim has unveiled its second kidney-focused collaboration in recent weeks, this time penning a deal worth over $120 million…
Read More
amgen-stitches-new-acquisition-worth-up-to-$840m-for-uk-biotech-and-its-cancer-programs
Posted inBiotechnology

Amgen stitches new acquisition worth up to $840M for UK biotech and its cancer programs

January 6, 2026
Amgen is adding Dark Blue to its tapestry, embedding the U.K. biotech’s preclinical blood cancer program into its organization. The…
Read More
arrowhead-takes-aim-at-obesity-market-with-early-data-on-dual-gene-silencing-assets
Posted inBiotechnology

Arrowhead takes aim at obesity market with early data on dual gene silencing assets

January 6, 2026
Arrowhead Pharmaceuticals has reported early-phase data on a pair of gene silencing drug candidates in obesity, posting preliminary evidence that the…
Read More
in-structure-licensing-deal,-roche-commits-$100m-to-shore-up-glp-1-position
Posted inBiotechnology

In Structure licensing deal, Roche commits $100M to shore up GLP-1 position

January 6, 2026
In a strategic move that could protect its obesity pipeline from future patent litigation, Roche is paying $100 million to…
Read More
lilly-returns-to-nimbus-with-$1.3b-deal-to-create-new-oral-obesity-drug
Posted inBiotechnology

Lilly returns to Nimbus with $1.3B deal to create new oral obesity drug

January 6, 2026
Eli Lilly has returned to Nimbus Therapeutics for another metabolic collaboration, this time focused on the red-hot R&D space of…
Read More
brainspace-garners-fda-clearance-for-brain-fluid-management-system
Posted inMedical Technology

BrainSpace garners FDA clearance for brain fluid management system

January 6, 2026
BrainSpace, a medtech focused on neurological injuries and illnesses, received 501(k) clearance from the FDA for its brain fluid management…
Read More
alumis-beams-as-pivotal-data-on-sotyktu-rival-drive-stock-surge
Posted inBiotechnology

Alumis beams as pivotal data on Sotyktu rival drive stock surge

January 6, 2026
A pair of phase 3 psoriasis studies of Alumis’ TYK2 inhibitor have hit their primary endpoints, setting the biotech up to…
Read More
instil’s-stock-sinks-after-it-clears-out-pipeline,-hands-2-drugs-back-to-immuneonco
Posted inBiotechnology

Instil’s stock sinks after it clears out pipeline, hands 2 drugs back to ImmuneOnco

January 6, 2026
Instil Bio’s hopes for its refreshed clinical pipeline appear to have ended in failure, with the U.S. biotech handing the…
Read More
minimum-wage-laws-impact-food-security-across-states
Posted inBiotechnology

Minimum Wage Laws Impact Food Security Across States

January 6, 2026
The intricate relationship between minimum wage legislation and food security has become an urgent focus in public health research, particularly…
Read More

Posts pagination

Previous page 1 … 774 775 776 777 778 … 803 Next page

Privacy Policy    Terms

Scroll to Top